Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-01 Purchase | 2024-03-05 4:58 pm | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 14,500 | $1.2383 | $17,955 | 28,863 (Direct) | View |
| 2023-10-23 Sale | 2023-10-25 4:28 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 6,000 | $5.0767 | $30,460 | 129,917 (Indirect Direct) | View |
| 2023-09-06 Purchase | 2023-09-07 4:16 pm | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 9,490 | $7.9 | $74,971 | 15,461 (Direct) | View |
| 2023-08-28 Purchase | 2023-08-28 4:39 pm | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 14,705 | $6.7976 | $99,959 | 21,688 (Direct) | View |
| 2023-08-21 Sale | 2023-08-22 4:31 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 6,000 | $7.3158 | $43,895 | 135,917 (Indirect Direct) | View |
| 2023-06-20 Sale | 2023-06-22 4:30 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 6,000 | $10.28 | $61,663 | 141,917 (Indirect Direct) | View |
| 2023-03-17 Purchase | 2023-03-17 5:03 pm | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 6,300 | $7.8623 | $49,532 | 12,800 (Direct) | View |
| 2023-03-09 Purchase | 2023-03-09 5:56 pm | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 6,500 | $7.735 | $50,278 | 6,500 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 8:37 pm | Aclaris Therapeutics Inc. | ACRS | Walker Neal Director | 59,240 | $12.5 | $740,658 | 1,400,006 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 8:12 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 30,837 | $12.51 | $385,639 | 293,192 (Indirect Direct) | View |
| 2023-03-02 Sale | 2023-03-03 8:09 pm | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 1,894 | $12.45 | $23,579 | 16,081 (Direct) | View |
| 2023-02-15 Sale | 2023-02-17 4:34 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 5,000 | $13.06 | $65,310 | 91,579 (Indirect Direct) | View |
| 2023-02-08 Sale | 2023-02-10 4:55 pm | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 4,267 | $13.89 | $59,272 | 6,983 (Direct) | View |
| 2023-02-01 Sale | 2023-02-03 5:09 pm | Aclaris Therapeutics Inc. | ACRS | Walker Neal Director | 30,000 | $16.66 | $499,923 | 1,175,763 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Exercise | 2024-04-03 5:00 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,408,755 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-03 5:00 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 3,224 | $1.26 | 1,408,755 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal Interim President and CEO | 9,466 | $0 | 1,411,979 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal Interim President and CEO | 3,223 | $1.24 | 1,411,979 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 5:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 73,425 | $0 | 258,826 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 21,283 | $1.24 | 258,826 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 5:02 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 4,975 | $0 | 29,833 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:02 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 1,417 | $1.24 | 29,833 (Direct) | View |
Ownership | 2024-02-08 10:47 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 0 | $0 | 9,395,934 (Indirect) | View |
| 2024-02-01 Option Award | 2024-02-05 7:36 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Walker Neal Interim CEO | 639,000 | $0 | 639,000 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 7:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 2,583 | $1.2 | 570,334 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-05 7:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 7,500 | $0 | 570,334 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:31 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 413,000 | $0 | 570,334 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 7:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 6,421 | $1.2 | 492,017 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-05 7:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 18,750 | $0 | 492,017 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:29 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 413,000 | $0 | 492,017 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:27 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 413,000 | $0 | 413,000 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-01-03 4:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 2,536 | $1.05 | 42,925 (Direct) | View |
| 2024-01-01 Exercise | 2024-01-03 4:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 7,500 | $0 | 42,925 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-01-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 9,125 | $1.05 | 122,813 (Direct) | View |
| 2024-01-01 Exercise | 2024-01-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 27,000 | $0 | 122,813 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-05 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 1,000 | $0 | 6,971 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-09-05 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 285 | $7.9 | 6,971 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-03 4:24 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 15,575 | $0 | 70,663 (Direct) | View |
| 2023-08-01 Tax Withholding | 2023-08-03 4:24 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 4,437 | $9.81 | 70,663 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-05 4:23 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Cawkwell Gail Chief Medical Officer | 15,000 | $0 | 54,593 (Direct) | View |
| 2023-07-01 Tax Withholding | 2023-07-05 4:23 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Cawkwell Gail Chief Medical Officer | 5,407 | $10.37 | 54,593 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 4:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 16,500 | $1.41 | 48,503 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 4:32 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 16,500 | $0 | 48,503 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 4:31 pm | N/A 2024-08-12 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 249 | $0 | 32,003 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 4:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 51 | $0.72 | 32,003 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 4:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 198 | $1.52 | 32,003 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 5:12 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 4,507 | $0 | 44,482 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:12 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 20,410 | $0 | 44,482 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 4,507 | $0 | 28,273 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:08 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 20,410 | $0 | 28,273 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 5:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,507 | $0 | 32,711 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:04 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 20,410 | $0 | 32,711 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 5:02 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 4,507 | $0 | 52,164 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:02 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 20,410 | $0 | 52,164 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 4:57 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 4,507 | $0 | 44,482 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:57 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 20,410 | $0 | 44,482 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 4:53 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 4,507 | $0 | 459,372 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:53 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 20,410 | $0 | 459,372 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 4:50 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 4,507 | $0 | 34,773 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:50 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 20,410 | $0 | 34,773 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 4:45 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 4,507 | $0 | 59,114 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:45 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 20,410 | $0 | 59,114 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 8:37 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal Director | 156,679 | $0 | 1,400,006 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 8:12 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 87,175 | $0 | 293,192 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 8:09 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 6,450 | $0 | 16,081 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:07 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:04 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 486,000 | $0 | 486,000 (Direct) | View |